simendan has been researched along with Cardiac Output, Low in 98 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 35 (35.71) | 29.6817 |
| 2010's | 46 (46.94) | 24.3611 |
| 2020's | 17 (17.35) | 2.80 |
| Authors | Studies |
|---|---|
| Belletti, A; Bianzina, S; Momeni, M; Silvetti, S | 1 |
| Eagle, SS; Londergan, BP; Staudt, GE | 1 |
| Dosta-Herrera, JJ; Gutiérrez-Riveroll, KI; Mejía Picazo, HJ | 1 |
| Lapere, M; Rega, F; Rex, S | 1 |
| Alexander, JH; Argenziano, M; de Varennes, B; Duncan, AI; Fremes, S; Goodman, SG; Kochar, A; Lopes, RD; Mazer, DC; Mehta, RH; van Diepen, S; Westerhout, CM; Whitlock, R; Zheng, Y | 1 |
| Mielke, JAR; Ramakrishna, H; Welker, CC | 1 |
| Dresbach, T; Geipel, A; Holcher, S; Kipfmueller, F; Leyens, J; Mueller, A; Schroeder, L; Strizek, B | 1 |
| Barrera Serrano, R; Bellido Estevez, I; Cruz Mañas, J; Escalona Belmonte, JJ; Gomez Luque, A; Guerrero Orriach, JL; Hernandez Rodriguez, P; Malo Manso, A; Navarro Arce, I; Raigón Ponferrada, A; Ramirez Aliaga, M; Ramirez Fernandez, A; Rubio Navarro, M; Toledo Medina, CS | 1 |
| Choi, YH; Deppe, AC; Djordjevic, I; Eghbalzadeh, K; Esser, M; Liakopoulos, O; Madershahian, N; Maier, J; Merkle, J; Sabashnikov, A; Wahlers, TCW; Weber, C | 1 |
| Cui, C; Fan, Y; Tan, Q; Wang, A; Wang, F; Wang, G; Wang, J; Zhang, J; Zi, J | 1 |
| Di Chiara, L; Di Molfetta, A; Haiberger, R; Iacobelli, R; Marinari, E; Ricci, Z; Toscano, A | 1 |
| Beretta-Piccoli, X; Biarent, D; De Bels, D; Honore, PM; Redant, S | 1 |
| Abubakirov, MN; Belletti, A; Bianchi, A; Brazzi, L; Calabrò, MG; Crivellari, M; Di Tomasso, N; Fominskiy, EV; Garofalo, E; Grigoryev, EV; Guarracino, F; Landoni, G; Lembo, R; Likhvantsev, VV; Lomivorotov, VV; Monaco, F; Oriani, A; Pasyuga, VV; Paternoster, G; Pisano, A; Scandroglio, AM; Yavorovskiy, A; Zangrillo, A | 1 |
| Álvarez-Castillo, A; Ferrer-Rodríguez, J; García-González, MJ; Iribarren-Sarrías, JL; Jiménez-Rivera, JJ; Jorge-Pérez, P; Lacalzada-Almeida, J; Martínez-Sanz, R; Montoto-López, J; Pérez-Hernández, R | 1 |
| Dashkevich, A; Juchem, G; Kilger, E; Mehringer, L; Schünemann, M; Weis, M; Woehrle, T | 1 |
| Efremov, L; Frantz, S; Mikolajczyk, R; Schumann, J; Sedding, D; Tongers, J; Uhlig, K | 1 |
| Axelsson, B; Grafver, I; Jansson, K; Kiszakiewicz, L; Nilsson, KF; Oikonomakis, I; Seilitz, J | 1 |
| Filipiak, KJ; Gasecka, A; Jaguszewski, MJ; Szarpak, L | 1 |
| Belletti, A; Cassina, T; Clivio, S; Putzu, A | 1 |
| Alexander, JH; Anstrom, KJ; Argenziano, M; Bozinovski, J; Duncan, A; Fremes, S; Goodman, SG; Harrington, RA; Harrison, RW; Hay, D; Heringlake, M; Jankowich, R; Kalavrouziotis, D; Leimberger, JD; Levy, JH; Luber, J; Marcel, R; Mehta, RH; Meza, J; Murphy, E; Nagpal, D; Park, S; Soltesz, EG; Toller, W; van Diepen, S; Wang, A | 1 |
| Abubakirov, MN; Alvaro, G; Amantea, B; Baiocchi, M; Belletti, A; Bellomo, R; Bertini, P; Bianchi, A; Boboshko, VA; Bove, T; Brazzi, L; Calabrò, MG; Grigoryev, EV; Guarracino, F; Landoni, G; Lembo, R; Likhvantsev, VV; Lobreglio, R; Lomivorotov, VV; Michienzi, MG; Monaco, F; Pappalardo, F; Pasyuga, VV; Pisano, A; Salgado-Filho, MF; Scandroglio, AM; Shukevich, DL; Verniero, L; Zabelina, TS; Zangrillo, A | 1 |
| Desai, AS; Jarcho, JA | 1 |
| Hummel, J; Rücker, G; Stiller, B | 2 |
| Aït Hamou, N; Amour, J; Boughenou, MF; Boyer, J; Carillion, A; Caruba, T; Charles-Nelson, A; Chatellier, G; Cholley, B; Desebbe, O; Durand, M; Fellahi, JL; Girard, C; Grosjean, S; Guidon, C; Guinet, P; Lévy, F; Menasché, P; Miguet, B; Ouattara, A; Pirracchio, R; Radutoiu, M; Robin, E; Rosier, S; Rozec, B; Squara, P; Villacorta, J | 1 |
| Arcadipane, A; Knight, JB; Lorini, FL; Morelli, A; Pastore, F; Sanfilippo, F; Santonocito, C; Scolletta, S; Tritapepe, L | 1 |
| Frantz, S; Henrich, EC; Prondzinsky, R; Schumann, J; Strobl, H; Thiele, H; Unverzagt, S; Weiche, S; Werdan, K | 1 |
| Incalzi, RA; Massini, C; Migale, M; Santillo, E | 1 |
| Abowali, H; Abuzaid, AS; Elbadawi, A; Elgendy, IY; Goswamy, V; London, B; Megaly, M; Mentias, A; Saad, M; Shahin, HI | 1 |
| González, JM; González, L; Juarez, P; Portela, F; Sadaba, R; Santana, L; Tena, MÁ; Urso, S | 1 |
| Chen, P; Li, Z; Tian, X; Wang, J; Wang, Z; Wu, X; Yan, T | 1 |
| Cheng, B; Gong, Y; He, X; Wang, B | 1 |
| Di Molfetta, P; Fiore, C; Gregorini, R; Santarpino, G | 1 |
| Grebenshchikov, OA; Lar'kov, RN; Likhvantsev, VV; Marchenko, DN; Ovezov, AM; Philippovskaya, ZS; Skripkin, YV; Sungurov, VA; Timoshin, SS; Ubasev, YV; Zabelina, TS | 1 |
| Chen, L; He, Y; Qing, X; Zhang, Y; Zhu, J | 1 |
| Pirracchio, R | 1 |
| Fletcher, N | 1 |
| Caruba, T; Cholley, B | 1 |
| Banasiak, W; Biegus, J; Jankowska, EA; Kulej, K; Ponikowski, P; Szachniewicz, J; Zymliński, R | 1 |
| Alvarez, J; Baluja, A; Caruezo, V; Castroagudin, J; Otero, P; Rial, M; Rodriguez, A; Rodriguez, I; Rodriguez, J; Selas, S; Taboada, M; Tome, S; Veiras, S | 1 |
| Buerke, M; Haerting, J; Hirsch, K; Prondzinsky, R; Thiele, H; Unverzagt, S; Wachsmuth, L; Werdan, K | 1 |
| Firlinger, F; Gegenhuber, A; Lenz, K; Lohr, G; Piringer, P | 1 |
| Gluud, C; Keus, F; Koster, G; Scheeren, TW; van der Horst, IC; Wetterslev, J; Zijlstra, JG | 1 |
| Burkhardt, BE; Rücker, G; Stiller, B | 1 |
| Balzer, F; Braun, JP; Erb, JM; Geyer, T; Grubitzsch, H; Kastrup, M; Sander, M; Spies, CD; Treskatsch, S; Wernecke, KD | 1 |
| Altarabsheh, SE; Avery, EG; Cho, YH; Deo, SV; Hang, D; Lim, JY; Markowitz, AH; McGraw, M; Park, SJ; Rababa'h, A | 1 |
| Bautista-Hernandez, V; Ferrer-Barba, A; Gonzalez-Rivera, I | 1 |
| Ertl, G; Pauschinger, M; von Scheidt, W | 1 |
| Carriò, ML; Castro, MJ; Farrero, E; Javierre, C; Lopez-Delgado, JC; Periche, E; Pinseau, A; Rodríguez-Castro, D; Torrado, H; Toscano, JE; Ventura, JL | 1 |
| Alvaro, G; Amantea, B; Auci, E; Auriemma, S; Baiocchi, M; Bianchi, A; Biondi-Zoccai, G; Bove, T; Bradic, N; Buscaglia, G; Calabrò, MG; Cariello, C; Corcione, A; De Vuono, G; Fominskiy, E; Frontini, M; Galdieri, N; Gemma, M; Gianni, S; Grigoryev, E; Guarracino, F; Landoni, G; Lembo, R; Likhvantsev, V; Lipinski, MJ; Lobreglio, R; Lomivorotov, VV; Monaco, F; Pala, G; Paternoster, G; Pisano, A; Sangalli, F; Wang, CY; Zangrillo, A; Zucchetti, MC | 1 |
| Mauriat, P; Séguéla, PE; Tafer, N; Thambo, JB | 1 |
| Anastasiadis, K; Antonitsis, P; Argiriadou, H; Asteriou, C; Grosomanidis, V; Kleontas, A; Tossios, P; Vranis, K | 1 |
| Almeida, C; Aucouturier, P; Caruba, T; Chatellier, G; Cholley, B; Djadi-Prat, J; Freitas, N; Gomes, N; Hoffart-Jourdain, C; Hourton, D; Menasché, P; Rousseau, D; Sabatier, B; Souag, A; Tibi, A; Yjjou, M | 1 |
| Altinsoy, HB; Atalay, A; Atalay, H; Azboy, D; Colak, S; Dogan, OF; Temizturk, Z | 1 |
| Cantinotti, M; Giordano, R; Mannacio, VA; Palma, G | 1 |
| Boethig, D; Goerler, H; Huber, D; Osthaus, WA; Sasse, M; Sümpelmann, R; Winterhalter, M | 1 |
| González-Costello, J; Homs, S | 1 |
| Althabe, M; Balestrini, M; Chang, AC; Charroqui, A; Landry, LM; Lataza, E; Magliola, R; Moreno, G; Salgado, G; Vassallo, JC | 1 |
| Adanir, T; Aksun, M; Aran, G; Gürbüz, A; Karahan, N; Ozgürbüz, U; Oztürk, T; Sencan, A; Yetkin, U | 1 |
| Buerke, M; Lemm, H; Russ, M; Schlitt, A; Werdan, K | 1 |
| Bravo, MC; Bravo, Mdel C; Cabañas, F; López, P; Pellicer, A; Pérez-Fernández, E; Pérez-Rodríguez, J; Quero, J | 1 |
| Asopa, S; Elahi, MM; Lam, J; Matata, BM | 1 |
| Läer, S; Vogt, W | 1 |
| Cogo, PE; Di Chiara, L; Favia, I; Garisto, C; Ricci, Z; Vitale, V | 1 |
| Freynschlag, R; Gombotz, H; Hofer, A; Lechner, E; Leitner-Peneder, G; Mair, R; Rehak, P; Weinzettel, R | 1 |
| Algotsson, L; Guarracino, F; Hörmann, C; Knotzer, J; Landoni, G; Lehmann, A; Rajek, A; Salmenperä, M; Schirmer, U; Toller, W; Tritapepe, L; Weis, F | 1 |
| Caresta, E; Midulla, F; Moretti, C; Papoff, P; Pinto, R; Versacci, P | 1 |
| Abdalla, M; Cleland, JG; Follath, F; Harjola, VP; Just, H; Lehtonen, L; Mitrovic, V; Papp, JG; Peuhkurinen, K; Sandell, EP; Scholz, H | 1 |
| Apajasalo, M; Cleland, JG; Kobelt, G; Takala, A; Zethraeus, N | 1 |
| Nieminen, MS | 1 |
| Follath, F | 1 |
| Anifantakis, A; Athanassopoulos, G; Chatzigeorgiou, G; Cokkinos, DV; Iakovis, P; Karatasakis, G; Koutsogiannis, N; Manginas, A; Maounis, T; Papadakis, M; Spargias, KS | 1 |
| Cavana, M; Fraticelli, A; Mebazaa, A; Pignataro, C | 1 |
| Mason, P | 1 |
| Ewert, P; Hetzer, R; Lange, PE; Luther, YC; Mühler, EG; Nasseri, B; Redlin, M; Schulze-Neick, I; Stiller, B | 1 |
| Amantea, B; Carrata, F; Labriola, C; Santangelo, E; Siro-Brigiani, M | 1 |
| Ewert, P; Hetzer, R; Lange, PE; Lehmkuhl, HB; Luther, YC; Schulze-Neick, I | 1 |
| Ng, TM | 1 |
| Conti, G; De Castro, S; De Luca, L; Di Angelantonio, E; Morelli, A; Orecchioni, A; Pandian, NG; Pietropaoli, P; Rocco, M; Singer, M; Teboul, JL | 1 |
| Braun, JP; Doepfmer, UR; Dohmen, PM; Jasulaitis, D; Kastrup, M; Konertz, W; Moshirzadeh, M; Spies, C; von Heymann, C | 1 |
| Bouckaert, Y; Creteur, J; Mélot, C; Vincent, JL | 1 |
| Delgado, JF | 1 |
| Alvarez, J; Bouzada, M; Caruezo, V; Fernández, AL; García-Bengoechea, JB; Ginesta, V; González-Juanatey, JR; Rodríguez, J; Rubio, J; Taboada, M | 1 |
| Al-Shawaf, E; Ayed, A; Dehrab, N; Radomir, B; Tarazi, R; Vislocky, I | 1 |
| Butt, WW; Crossland, DS; Namachivayam, P; Shekerdemian, LS | 1 |
| Domínguez-Rodríguez, A; García-González, MJ | 1 |
| Wessel, DL | 1 |
| Bröking, K; Ertmer, C; Lange, M; Morelli, A; Rehberg, S; Van Aken, H; Westphal, M | 1 |
| Brizard, CP; Horton, SB; Mynard, JP; Nørgaard, MA; Penny, DJ; Shekerdemian, LS; Stocker, CF | 1 |
| Lechner, E; Mair, R; Moosbauer, W; Pinter, M; Tulzer, G | 1 |
| Bihari, D; Ramaswamykanive, H; Solano, TR | 1 |
| Antoniou, T; Degiannis, D; Geroulanos, S; Kriaras, I; Papadopoulos, K; Stavridis, G; Tasouli, A | 1 |
| Adreanides, E; Athanasopoulos, G; Cokkinos, DV; Dritsas, A; Giamouzis, G; Mavrogeni, S; Panagiotakos, D; Papadopoulou, E; Spargias, K; Thomopoulou, S; Vassiliadis, I | 1 |
| Ghazwinian, N; Hochmair, N; Mueller, T; Plöchl, W; Ponschab, M | 1 |
| Alvarez, J | 1 |
| Blanco, N; Botbol, AL; Degrange, MA; del Mazo, CD; Levin, RL; Porcile, R; Salvagio, F; Tanus, E | 1 |
| Endoh, M | 1 |
| Laine, M; Lehtonen, L; Nieminen, MS | 1 |
31 review(s) available for simendan and Cardiac Output, Low
| Article | Year |
|---|---|
Effect of Levosimendan Treatment in Pediatric Patients With Cardiac Dysfunction: An Update of a Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Topics: Adolescent; Cardiac Output, Low; Cardiotonic Agents; Child; Humans; Hydrazones; Pyridazines; Randomized Controlled Trials as Topic; Simendan | 2022 |
Levosimendan in paediatric cardiac anaesthesiology: A systematic review and meta-analysis.
Topics: Anesthesiology; Cardiac Output, Low; Cardiotonic Agents; Child; Humans; Hydrazones; Pyridazines; Simendan | 2022 |
Levosimendan and Low Cardiac Output After Cardiac Surgery: Analysis of Trial Data.
Topics: Cardiac Output, Low; Cardiac Surgical Procedures; Cardiotonic Agents; Humans; Hydrazones; Postoperative Complications; Simendan | 2023 |
Levosimendan Reduces Mortality and Low Cardiac Output Syndrome in Cardiac Surgery.
Topics: Cardiac Output, Low; Cardiac Surgical Procedures; Cardiotonic Agents; Heart Disease Risk Factors; Humans; Randomized Controlled Trials as Topic; Risk Assessment; Simendan; Treatment Outcome | 2020 |
Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome.
Topics: Aged; Cardiac Output, Low; Cardiotonic Agents; Cause of Death; Dobutamine; Enoximone; Epinephrine; Humans; Hydrazones; Middle Aged; Myocardial Infarction; Nitric Oxide; Placebos; Pyridazines; Randomized Controlled Trials as Topic; Shock, Cardiogenic; Simendan; Vasodilator Agents | 2020 |
Prophylactic levosimendan for the prevention of low cardiac output syndrome and mortality in paediatric patients undergoing surgery for congenital heart disease.
Topics: Assisted Circulation; Cardiac Output, Low; Cardiotonic Agents; Child, Preschool; Heart Defects, Congenital; Humans; Hydrazones; Infant; Intensive Care Units, Pediatric; Length of Stay; Postoperative Complications; Pyridazines; Randomized Controlled Trials as Topic; Respiration, Artificial; Simendan; Syndrome | 2017 |
Levosimendan for patients with severely reduced left ventricular systolic function and/or low cardiac output syndrome undergoing cardiac surgery: a systematic review and meta-analysis.
Topics: Cardiac Output, Low; Cardiac Surgical Procedures; Cardiotonic Agents; Humans; Hydrazones; Pyridazines; Simendan; Stroke Volume; Ventricular Function, Left | 2017 |
Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome.
Topics: Aged; Cardiac Output, Low; Cardiotonic Agents; Cause of Death; Dobutamine; Enoximone; Humans; Hydrazones; Middle Aged; Myocardial Infarction; Nitric Oxide; Pyridazines; Randomized Controlled Trials as Topic; Shock, Cardiogenic; Simendan; Vasodilator Agents | 2018 |
Levosimendan for Perioperative Cardioprotection: Myth or Reality?
Topics: Cardiac Output, Low; Cardiotonic Agents; Humans; Hydrazones; Postoperative Complications; Pyridazines; Retrospective Studies; Simendan | 2018 |
Meta-Analysis of Trials on Prophylactic Use of Levosimendan in Patients Undergoing Cardiac Surgery.
Topics: Cardiac Output, Low; Cardiac Surgical Procedures; Cardiotonic Agents; Humans; Simendan | 2018 |
Levosimendan versus placebo in cardiac surgery: a systematic review and meta-analysis.
Topics: Cardiac Output, Low; Cardiac Surgical Procedures; Cardiotonic Agents; Humans; Postoperative Complications; Simendan | 2018 |
Effects of levosimendan on mortality in patients undergoing cardiac surgery: A systematic review and meta-analysis.
Topics: Cardiac Output, Low; Cardiac Surgical Procedures; Databases, Bibliographic; Humans; Hydrazones; Phosphodiesterase Inhibitors; Postoperative Complications; Pyridazines; Randomized Controlled Trials as Topic; Simendan | 2018 |
Levosimendan in Patients with Left Ventricular Dysfunction Undergoing Cardiac Surgery: An Update Meta-Analysis and Trial Sequential Analysis.
Topics: Cardiac Output, Low; Cardiac Surgical Procedures; Cardiotonic Agents; Humans; Hydrazones; Postoperative Complications; Pyridazines; Randomized Controlled Trials as Topic; Renal Replacement Therapy; Simendan; Ventricular Dysfunction, Left | 2018 |
Levosimendan in patients with low cardiac output syndrome undergoing cardiac surgery: A systematic review and meta-analysis.
Topics: Acute Kidney Injury; Cardiac Output; Cardiac Output, Low; Cardiac Surgical Procedures; Cardiotonic Agents; Humans; Myocardial Infarction; Odds Ratio; Placebos; Postoperative Complications; Randomized Controlled Trials as Topic; Simendan; Time Factors | 2019 |
Inotropic agents and vasodilator strategies for acute myocardial infarction complicated by cardiogenic shock or low cardiac output syndrome.
Topics: Cardiac Output, Low; Cardiotonic Agents; Dobutamine; Enoximone; Humans; Hydrazones; Myocardial Infarction; Nitric Oxide; Pyridazines; Randomized Controlled Trials as Topic; Shock, Cardiogenic; Simendan; Vasodilator Agents | 2014 |
Effects of levosimendan for low cardiac output syndrome in critically ill patients: systematic review with meta-analysis and trial sequential analysis.
Topics: Cardiac Output, Low; Cardiotonic Agents; Critical Illness; Humans; Hydrazones; Pyridazines; Simendan; Treatment Outcome | 2015 |
Prophylactic milrinone for the prevention of low cardiac output syndrome and mortality in children undergoing surgery for congenital heart disease.
Topics: Cardiac Output, Low; Cardiotonic Agents; Dobutamine; Heart Defects, Congenital; Humans; Hydrazones; Infant; Infant, Newborn; Milrinone; Postoperative Complications; Pyridazines; Randomized Controlled Trials as Topic; Simendan; Syndrome; Time Factors | 2015 |
Levosimendan Reduces Mortality in Adults with Left Ventricular Dysfunction Undergoing Cardiac Surgery: A Systematic Review and Meta-analysis.
Topics: Acute Kidney Injury; Adult; Cardiac Output, Low; Cardiac Surgical Procedures; Cardiotonic Agents; Databases, Bibliographic; Humans; Hydrazones; Postoperative Complications; Pyridazines; Randomized Controlled Trials as Topic; Simendan; Ventricular Dysfunction, Left | 2015 |
Inodilators in the Management of Low Cardiac Output Syndrome After Pediatric Cardiac Surgery.
Topics: Animals; Cardiac Output, Low; Cardiac Surgical Procedures; Cardiotonic Agents; Child; Humans; Hydrazones; Milrinone; Phosphodiesterase Inhibitors; Pyridazines; Simendan; Vasodilator Agents | 2016 |
Long-term intravenous inotropes in low-output terminal heart failure?
Topics: Administration, Intravenous; Cardiac Output; Cardiac Output, Low; Cardiotonic Agents; Chi-Square Distribution; Dobutamine; Drug Administration Schedule; Heart Failure; Heart Transplantation; Humans; Hydrazones; Milrinone; Odds Ratio; Practice Guidelines as Topic; Pyridazines; Risk Factors; Simendan; Time Factors; Treatment Outcome; Waiting Lists | 2016 |
[Use of levosimendan in children].
Topics: Cardiac Output, Low; Cardiotonic Agents; Child; Extracorporeal Circulation; Heart Failure; Humans; Hydrazones; Postoperative Complications; Pyridazines; Simendan | 2016 |
Prophylactic levosimendan for the prevention of low cardiac output syndrome and mortality in paediatric patients undergoing surgery for congenital heart disease.
Topics: Assisted Circulation; Cardiac Output, Low; Cardiotonic Agents; Coronary Care Units; Heart Defects, Congenital; Humans; Hydrazones; Length of Stay; Postoperative Complications; Pyridazines; Randomized Controlled Trials as Topic; Respiration, Artificial; Simendan | 2017 |
[Therapeutic strategies in acute decompensated heart failure and cardiogenic shock].
Topics: Aged; Cardiac Output, Low; Cardiotonic Agents; Combined Modality Therapy; Comorbidity; Critical Care; Cross-Sectional Studies; Diuretics; Emergency Service, Hospital; Heart Failure; Hospitalization; Humans; Hydrazones; Multicenter Studies as Topic; Myocardial Revascularization; Population Dynamics; Pyridazines; Risk Factors; Shock, Cardiogenic; Simendan; Vasodilator Agents | 2010 |
Levosimendan versus an intra-aortic balloon pump in adult cardiac surgery patients with low cardiac output.
Topics: Algorithms; Cardiac Output; Cardiac Output, Low; Cardiac Surgical Procedures; Cardiotonic Agents; Humans; Hydrazones; Intra-Aortic Balloon Pumping; Myocardial Stunning; Preoperative Care; Pyridazines; Randomized Controlled Trials as Topic; Risk Assessment; Simendan | 2011 |
Perioperative use of levosimendan: best practice in operative settings.
Topics: Cardiac Output, Low; Cardiac Surgical Procedures; Cardiotonic Agents; Critical Illness; Humans; Hydrazones; Perioperative Care; Pyridazines; Randomized Controlled Trials as Topic; Simendan; Surgical Procedures, Operative | 2013 |
The clinical experience with levosimendan in anesthesiology and in the intensive care unit.
Topics: Adrenergic beta-Antagonists; Anesthesia; Calcium Channels, L-Type; Cardiac Output, Low; Cardiac Surgical Procedures; Cardiotonic Agents; Heart Failure; Humans; Hydrazones; Intensive Care Units; Myocardial Contraction; Pyridazines; Shock, Cardiogenic; Simendan; Systole; Ventricular Dysfunction, Left | 2003 |
Levosimendan.
Topics: Cardiac Output, Low; Cardiotonic Agents; Humans; Hydrazones; Pyridazines; Simendan | 2003 |
Levosimendan, a new calcium-sensitizing inotrope for heart failure.
Topics: Animals; Calcium; Cardiac Output, Low; Cardiotonic Agents; Clinical Trials as Topic; Humans; Hydrazones; Myocardial Contraction; Pyridazines; Simendan; Treatment Outcome | 2004 |
[Levosimendan in acute heart failure: past, present and future].
Topics: Acute Disease; Cardiac Output, Low; Cardiotonic Agents; Clinical Trials as Topic; Forecasting; Humans; Hydrazones; Pyridazines; Simendan | 2006 |
[Role of Levosimendan in intensive care treatment of myocardial insufficiency].
Topics: Calcium; Cardiac Output, Low; Cardiotonic Agents; Critical Care; Humans; Hydrazones; Myocardial Ischemia; Postoperative Care; Pyridazines; Simendan | 2007 |
Mechanism of action of Ca2+ sensitizers--update 2001.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Calcium; Calcium Signaling; Cardiac Output, Low; Cardiotonic Agents; Hemodynamics; Humans; Hydrazones; Myocardial Contraction; Pyridazines; Simendan | 2001 |
27 trial(s) available for simendan and Cardiac Output, Low
| Article | Year |
|---|---|
[Levosimendan for preventing low output syndrome in pediatric patients with correction of tetralogy of Fallot].
Topics: Cardiac Output, Low; Cardiotonic Agents; Child; Humans; Hydrazones; Longitudinal Studies; Milrinone; Prospective Studies; Pyridazines; Simendan; Syndrome; Tetralogy of Fallot | 2022 |
Predictors and associated clinical outcomes of low cardiac output syndrome following cardiac surgery: insights from the LEVO-CTS trial.
Topics: Cardiac Output, Low; Cardiac Surgical Procedures; Cardiotonic Agents; Humans; Hydrazones; Postoperative Complications; Pyridazines; Simendan; Ventricular Dysfunction, Left | 2022 |
Preservation of renal function in cardiac surgery patients with low cardiac output syndrome: levosimendan vs beta agonists.
Topics: Adrenergic beta-Agonists; Aged; Aged, 80 and over; Cardiac Output, Low; Cardiac Surgical Procedures; Cardiotonic Agents; Female; Humans; Incidence; Male; Middle Aged; Postoperative Complications; Renal Insufficiency; Simendan | 2019 |
Prophylactic use of levosimendan in pediatric patients undergoing cardiac surgery: a prospective randomized controlled trial.
Topics: Biomarkers; Cardiac Output, Low; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Cardiotonic Agents; Child, Preschool; Double-Blind Method; Female; Heart Defects, Congenital; Hemodynamics; Humans; Incidence; Infant; Kaplan-Meier Estimate; Length of Stay; Male; Postoperative Complications; Prospective Studies; Respiration, Artificial; Simendan; Treatment Outcome | 2019 |
Long-term outcome of perioperative low cardiac output syndrome in cardiac surgery: 1-year results of a multicenter randomized trial.
Topics: Age Factors; Cardiac Output, Low; Cardiotonic Agents; Cardiovascular Surgical Procedures; Double-Blind Method; Female; Humans; Male; Middle Aged; Postoperative Complications; Simendan; Survival Analysis; Treatment Outcome | 2020 |
Levosimendan in Patients with Left Ventricular Dysfunction Undergoing Cardiac Surgery.
Topics: Aged; Cardiac Output, Low; Cardiac Surgical Procedures; Cardiotonic Agents; Double-Blind Method; Female; Heart-Assist Devices; Humans; Hydrazones; Infusions, Intravenous; Male; Middle Aged; Mortality; Myocardial Infarction; Perioperative Period; Postoperative Complications; Pyridazines; Renal Replacement Therapy; Simendan; Stroke Volume; Treatment Failure; Ventricular Dysfunction, Left | 2017 |
Levosimendan for Hemodynamic Support after Cardiac Surgery.
Topics: Aged; Cardiac Output, Low; Cardiac Surgical Procedures; Cardiotonic Agents; Double-Blind Method; Female; Hemodynamics; Humans; Hydrazones; Infusions, Intravenous; Length of Stay; Male; Middle Aged; Mortality; Perioperative Period; Postoperative Complications; Pyridazines; Respiration, Artificial; Simendan; Stroke Volume; Treatment Failure | 2017 |
Effect of Levosimendan on Low Cardiac Output Syndrome in Patients With Low Ejection Fraction Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass: The LICORN Randomized Clinical Trial.
Topics: Aged; Cardiac Output, Low; Cardiopulmonary Bypass; Cardiotonic Agents; Catecholamines; Coronary Artery Bypass; Double-Blind Method; Female; Heart-Assist Devices; Humans; Hydrazones; Infusions, Intravenous; Intention to Treat Analysis; Male; Middle Aged; Postoperative Complications; Premedication; Pyridazines; Renal Replacement Therapy; Simendan; Stroke Volume; Treatment Failure | 2017 |
PREVENTION OF HEART FAILURE PATIENTS WITH DECREASED EJECTION FRACTION IN NON-CARDIAC SURGERY: LEVOSIMENDAN OR ANESTHETIC CARDIOPROTECTION?.
Topics: Aged; Anesthesia, General; Aorta; Cardiac Output, Low; Cardiopulmonary Bypass; Cardiotonic Agents; Female; Heart Failure; Humans; Hydrazones; Male; Perioperative Period; Prospective Studies; Pyridazines; Retrospective Studies; Simendan; Treatment Outcome | 2016 |
A comparison of dobutamine and levosimendan on hepatic blood flow in patients with a low cardiac output state after cardiac surgery: a randomised controlled study.
Topics: Aged; Cardiac Output, Low; Cardiac Surgical Procedures; Cardiotonic Agents; Dobutamine; Female; Hemodynamics; Humans; Hydrazones; Liver Circulation; Male; Postoperative Complications; Pyridazines; Simendan; Vascular Resistance | 2013 |
A randomized controlled trial of levosimendan to reduce mortality in high-risk cardiac surgery patients (CHEETAH): Rationale and design.
Topics: Acute Kidney Injury; Cardiac Output, Low; Cardiac Surgical Procedures; Cardiotonic Agents; Double-Blind Method; Humans; Hydrazones; Infusions, Intravenous; Intensive Care Units; Intra-Aortic Balloon Pumping; Length of Stay; Postoperative Complications; Pyridazines; Respiration, Artificial; Simendan | 2016 |
Effectiveness of prophylactic levosimendan in patients with impaired left ventricular function undergoing coronary artery bypass grafting: a randomized pilot study.
Topics: Cardiac Output, Low; Cardiotonic Agents; Coronary Artery Bypass; Coronary Artery Disease; Dose-Response Relationship, Drug; Double-Blind Method; Female; Finland; Follow-Up Studies; Humans; Hydrazones; Incidence; Infusions, Intravenous; Male; Middle Aged; Pilot Projects; Postoperative Complications; Prospective Studies; Pyridazines; Simendan; Stroke Volume; Survival Rate; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left; Ventricular Function, Left | 2016 |
Rationale and design of the multicenter randomized trial investigating the effects of levosimendan pretreatment in patients with low ejection fraction (≤40 %) undergoing CABG with cardiopulmonary bypass (LICORN study).
Topics: Cardiac Output, Low; Cardiopulmonary Bypass; Cardiotonic Agents; Coronary Artery Bypass; Double-Blind Method; Heart-Assist Devices; Humans; Hydrazones; Perioperative Period; Pyridazines; Renal Replacement Therapy; Research Design; Simendan; Stroke Volume; Ventricular Dysfunction, Left | 2016 |
[Levosimendan, a new inotropic drug: experience in children with acute heart failure].
Topics: Acute Disease; Adolescent; Cardiac Output, Low; Cardiotonic Agents; Child; Child, Preschool; Female; Humans; Hydrazones; Infant; Male; Prospective Studies; Pyridazines; Simendan | 2009 |
Levosimendan infusion in newborns after corrective surgery for congenital heart disease: randomized controlled trial.
Topics: Cardiac Output, Low; Cardiac Surgical Procedures; Cardiotonic Agents; Heart Defects, Congenital; Humans; Hydrazones; Infant, Newborn; Infusions, Intravenous; Italy; Outcome Assessment, Health Care; Postoperative Complications; Pyridazines; Simendan | 2012 |
Levosimendan versus milrinone in neonates and infants after corrective open-heart surgery: a pilot study.
Topics: Analysis of Variance; Body Surface Area; Cardiac Output; Cardiac Output, Low; Cardiopulmonary Bypass; Cardiotonic Agents; Double-Blind Method; Female; Heart Defects, Congenital; Humans; Hydrazones; Infant; Infant, Newborn; Intention to Treat Analysis; Male; Milrinone; Pilot Projects; Premedication; Pyridazines; Simendan; Statistics, Nonparametric | 2012 |
Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial.
Topics: Cardiac Output, Low; Cardiotonic Agents; Dobutamine; Double-Blind Method; Female; Hemodynamics; Humans; Hydrazones; Male; Middle Aged; Pyridazines; Simendan; Treatment Outcome | 2002 |
Intravenous levosimendan treatment is cost-effective compared with dobutamine in severe low-output heart failure: an analysis based on the international LIDO trial.
Topics: Aged; Cardiac Output, Low; Cardiotonic Agents; Cost-Benefit Analysis; Dobutamine; Double-Blind Method; Europe; Female; Follow-Up Studies; Heart Failure; Humans; Hydrazones; Infusions, Intravenous; Length of Stay; Life Expectancy; Male; Middle Aged; Patient Admission; Pyridazines; Randomized Controlled Trials as Topic; Risk Factors; Sensitivity and Specificity; Severity of Illness Index; Simendan; Survival Analysis; Treatment Outcome | 2003 |
Levosimendan compared with dobutamine in low output patients.
Topics: Cardiac Output, Low; Cardiotonic Agents; Dobutamine; Double-Blind Method; Hemodynamics; Humans; Hydrazones; Pulmonary Wedge Pressure; Pyridazines; Simendan | 2003 |
Levosimendan in patients with low-output heart failure: lessons from the LIDO trial.
Topics: Adrenergic beta-Agonists; Calcium Channels, L-Type; Cardiac Output, Low; Cardiotonic Agents; Death, Sudden, Cardiac; Dobutamine; Dose-Response Relationship, Drug; Double-Blind Method; Europe; Heart Failure; Heart Rate; Humans; Hydrazones; Infusions, Intravenous; Morbidity; Myocardial Contraction; Pulmonary Wedge Pressure; Pyridazines; Risk Factors; Severity of Illness Index; Shock, Cardiogenic; Simendan; Stroke Volume; Survival Analysis; Time; Treatment Outcome; Vasodilator Agents; Ventricular Dysfunction, Left | 2003 |
Hemodynamic effects of levosimendan in patients with low-output heart failure after cardiac surgery.
Topics: Aged; Aged, 80 and over; Cardiac Output, Low; Cardiac Surgical Procedures; Cardiotonic Agents; Female; Hemodynamics; Humans; Hydrazones; Infusions, Intravenous; Male; Middle Aged; Pyridazines; Simendan | 2004 |
Effects of levosimendan on systemic and regional hemodynamics in septic myocardial depression.
Topics: Cardiac Output, Low; Cardiotonic Agents; Female; Gastric Mucosa; Hemodynamics; Humans; Hydrazones; Male; Middle Aged; Pyridazines; Shock, Septic; Simendan; Statistics, Nonparametric | 2005 |
[Hemodynamic effects of levosimendan compared with dobutamine in patients with low cardiac output after cardiac surgery].
Topics: Aged; Cardiac Output, Low; Cardiac Surgical Procedures; Cardiotonic Agents; Dobutamine; Female; Hemodynamics; Humans; Hydrazones; Male; Prospective Studies; Pyridazines; Simendan | 2006 |
Levosimendan or milrinone in the type 2 diabetic patient with low ejection fraction undergoing elective coronary artery surgery.
Topics: Adult; Aged; Blood Pressure; Cardiac Output, Low; Cardiopulmonary Bypass; Coronary Artery Bypass; Diabetes Mellitus, Type 2; Elective Surgical Procedures; Female; Humans; Hydrazones; Male; Middle Aged; Milrinone; Phosphodiesterase Inhibitors; Pyridazines; Simendan; Stroke Volume; Vascular Resistance | 2006 |
Efficacy and safety of perioperative infusion of levosimendan in patients with compromised cardiac function undergoing open-heart surgery: importance of early use.
Topics: Aged; Anti-Arrhythmia Agents; Cardiac Output, Low; Cardiopulmonary Bypass; Cardiotonic Agents; Dose-Response Relationship, Drug; Female; Hemodynamics; Humans; Hydrazones; Intraoperative Complications; Male; Middle Aged; Pyridazines; Simendan; Syndrome; Treatment Outcome | 2007 |
A 6-month follow-up of intermittent levosimendan administration effect on systolic function, specific activity questionnaire, and arrhythmia in advanced heart failure.
Topics: Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Output, Low; Cardiotonic Agents; Drug Administration Schedule; Echocardiography; Electrocardiography, Ambulatory; Female; Follow-Up Studies; Humans; Hydrazones; Middle Aged; Mitral Valve Insufficiency; Myocardial Contraction; Pyridazines; Simendan; Stroke Volume; Surveys and Questionnaires; Systole; Ventricular Dysfunction, Left; Ventricular Function, Left | 2007 |
[The calcium sensitizer levosimendan gives superior results to dobutamine in postoperative low cardiac output syndrome].
Topics: Cardiac Output, Low; Cardiotonic Agents; Dobutamine; Female; Humans; Hydrazones; Male; Middle Aged; Postoperative Complications; Prospective Studies; Pyridazines; Simendan | 2008 |
40 other study(ies) available for simendan and Cardiac Output, Low
| Article | Year |
|---|---|
Take It or Levo It: An Updated Look at the Use of Levosimendan to Prevent Low Cardiac Output Syndrome in Pediatric Patients.
Topics: Cardiac Output, Low; Child; Humans; Hydrazones; Pyridazines; Simendan | 2022 |
Evaluation of levosimendan as treatment option in a large case-series of preterm infants with cardiac dysfunction and pulmonary hypertension.
Topics: Adult; Calcium; Cardiac Output, Low; Cardiotonic Agents; Child; Humans; Hypertension, Pulmonary; Infant; Infant, Newborn; Infant, Premature; Lactates; Simendan; Ventricular Dysfunction, Left | 2023 |
Effects of levosimendan on ventriculo-arterial coupling and cardiac efficiency in paediatric patients with single-ventricle physiology after surgical palliation: retrospective study.
Topics: Cardiac Output, Low; Cardiotonic Agents; Echocardiography; Female; Heart Failure; Humans; Hypoplastic Left Heart Syndrome; Infant; Infant, Newborn; Male; Retrospective Studies; Simendan; Stroke Volume; Univentricular Heart; Ventricular Function, Left | 2020 |
Prophylactic use of levosimendan in pediatric patients undergoing cardiac surgery: the jury is still out.
Topics: Cardiac Output, Low; Cardiac Surgical Procedures; Child; Humans; Prospective Studies; Simendan | 2020 |
Preconditioning with levosimendan reduces postoperative low cardiac output in moderate-severe systolic dysfunction patients who will undergo elective coronary artery bypass graft surgery: a cost-effective strategy.
Topics: Aged; Cardiac Output, Low; Cardiotonic Agents; Coronary Artery Bypass; Coronary Artery Disease; Cost-Benefit Analysis; Elective Surgical Procedures; Female; Humans; Incidence; Male; Postoperative Complications; Simendan; Spain; Stroke Volume; Ventricular Function, Left | 2020 |
[Individualized use of levosimendan in cardiac surgery].
Topics: Cardiac Output, Low; Cardiac Surgical Procedures; Cardiotonic Agents; Humans; Hydrazones; Postoperative Complications; Pyridazines; Retrospective Studies; Simendan; Stroke Volume; Ventricular Function, Left | 2021 |
A Randomized Porcine Study in Low Cardiac Output of Vasoactive and Inotropic Drug Effects on the Gastrointestinal Tract.
Topics: Animals; Cardiac Output, Low; Disease Models, Animal; Female; Gastrointestinal Tract; Male; Milrinone; Norepinephrine; Random Allocation; Simendan; Splanchnic Circulation; Swine; Vasodilator Agents; Vasopressins | 2021 |
Levosimendan or dobutamine in patients with low cardiac output syndrome: Results from meta-analysis.
Topics: Cardiac Output, Low; Cardiac Surgical Procedures; Dobutamine; Humans; Hydrazones; Pyridazines; Simendan | 2021 |
Reply to: Levosimendan or dobutamine in patients with low cardiac output syndrome: Results from meta-analysis.
Topics: Cardiac Output, Low; Dobutamine; Humans; Hydrazones; Pyridazines; Simendan | 2021 |
Levosimendan for the Low Cardiac Output Syndrome after Cardiac Surgery.
Topics: Cardiac Output, Low; Cardiac Surgical Procedures; Cardiotonic Agents; Humans; Hydrazones; Pyridazines; Simendan | 2017 |
Is There Still Room for the Prophylactic Use of Levosimendan in Cardiac Surgery?
Topics: Cardiac Output, Low; Cardiac Surgical Procedures; Humans; Simendan | 2018 |
Should we still prescribe Levosimendan for low cardiac output after cardiac surgery? Perhaps in the good patients!
Topics: Cardiac Output, Low; Cardiac Surgical Procedures; Humans; Hydrazones; Simendan | 2019 |
CON: Levosimendan should be used in clinical practice for patients with significantly impaired left ventricular function undergoing cardiac surgery.
Topics: Cardiac Output, Low; Cardiac Surgical Procedures; Humans; Hydrazones; Simendan; Ventricular Function, Left | 2019 |
Should we keep levosimendan in our pharmacies? Yes, undoubtedly!
Topics: Cardiac Output, Low; Cardiac Surgical Procedures; Humans; Hydrazones; Pharmacies; Pyridazines; Simendan | 2019 |
[Application of levosimendan in acute heart failure patients with symptoms of low cardiac output: case series report].
Topics: Adult; Aged; Cardiac Output, Low; Cardiotonic Agents; Heart Failure; Hemodynamics; Humans; Hydrazones; Infusions, Intravenous; Male; Middle Aged; Pyridazines; Simendan | 2013 |
[Pilot study of levosimendan : Effect on liver blood flow and liver function in acute decompensated heart failure].
Topics: Adult; Aged; Cardiac Output, Low; Cardiotonic Agents; Female; Heart Failure; Hemodynamics; Humans; Hydrazones; Indocyanine Green; Infusions, Intravenous; Liver; Liver Failure; Liver Function Tests; Male; Middle Aged; Pilot Projects; Pyridazines; Regional Blood Flow; Simendan | 2014 |
Early levosimendan administration is associated with decreased mortality after cardiac surgery.
Topics: Aged; Cardiac Output, Low; Cardiac Surgical Procedures; Cardiotonic Agents; Coronary Artery Bypass; Female; Heart Valve Prosthesis Implantation; Hospital Mortality; Humans; Hydrazones; Intensive Care Units; Logistic Models; Male; Middle Aged; Odds Ratio; Postoperative Complications; Proportional Hazards Models; Pyridazines; Renal Insufficiency; Renal Replacement Therapy; Retrospective Studies; Simendan; Stroke Volume; Survival Rate; Time Factors; Ventricular Dysfunction, Left; Ventricular Function, Left | 2015 |
Five-year mortality in cardiac surgery patients with low cardiac output syndrome treated with levosimendan: prognostic evaluation of NT-proBNP and C-reactive protein.
Topics: Aged; C-Reactive Protein; Cardiac Output, Low; Cardiac Surgical Procedures; Cardiotonic Agents; Female; Follow-Up Studies; Humans; Hydrazones; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Prognosis; Proportional Hazards Models; Prospective Studies; Pyridazines; Risk Factors; Simendan; Time Factors; Treatment Outcome | 2016 |
Levosimendan Use Increases Cardiac Performance after Coronary Artery Bypass Grafting in End-Stage Renal Disease Patients.
Topics: Aged; Cardiac Output, Low; Coronary Artery Bypass; Female; Hemodynamics; Humans; Hydrazones; Kidney Failure, Chronic; Male; Middle Aged; Postoperative Complications; Preoperative Care; Pyridazines; Simendan; Vasodilator Agents | 2016 |
First Experience With Levosimendan Therapy After Correction of Congenital Heart Disease.
Topics: Cardiac Output, Low; Cardiac Surgical Procedures; Cardiotonic Agents; Child; Child, Preschool; Female; Heart Defects, Congenital; Hemodynamics; Humans; Hydrazones; Infant; Infusions, Intravenous; Male; Postoperative Care; Pyridazines; Simendan | 2017 |
First experiences with intraoperative Levosimendan in pediatric cardiac surgery.
Topics: Cardiac Output; Cardiac Output, Low; Cardiac Surgical Procedures; Cardiotonic Agents; Heart; Heart Defects, Congenital; Hemodynamics; Humans; Hydrazones; Infant; Infant, Newborn; Infusions, Intravenous; Intraoperative Period; Lactic Acid; Length of Stay; Oxygen; Postoperative Complications; Pyridazines; Respiration, Artificial; Retrospective Studies; Simendan; Transposition of Great Vessels | 2009 |
[Superiority of levosimendan to dobutamine in postoperative low cardiac output syndrome: is it due to previous beta-blocker treatment?].
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Cardiac Output, Low; Dobutamine; Drug Interactions; Humans; Hydrazones; Length of Stay; Pyridazines; Randomized Controlled Trials as Topic; Simendan; Vasodilator Agents | 2008 |
Timing of levosimendan in cardiac surgery.
Topics: Aged; Cardiac Output, Low; Cardiotonic Agents; Drug Administration Schedule; Female; Hemodynamics; Humans; Hydrazones; Intraoperative Care; Male; Middle Aged; Myocardial Contraction; Patient Selection; Postoperative Care; Pyridazines; Retrospective Studies; Simendan; Time Factors; Ventricular Dysfunction, Left | 2009 |
Acute effects of levosimendan on cerebral and systemic perfusion and oxygenation in newborns: an observational study.
Topics: Blood Pressure; Cardiac Output, Low; Cardiotonic Agents; Cerebrovascular Circulation; Heart Defects, Congenital; Heart Rate; Hemoglobins; Humans; Hydrazones; Infant, Newborn; Lactic Acid; Prospective Studies; Pyridazines; Respiration; Simendan; Statistics, Nonparametric | 2011 |
Prevention for pediatric low cardiac output syndrome: results from the European survey EuLoCOS-Paed.
Topics: Cardiac Output, Low; Cardiac Surgical Procedures; Cardiotonic Agents; Child, Preschool; Dobutamine; Dopamine; Drug Therapy, Combination; Epinephrine; Europe; Health Care Surveys; Hospitals; Humans; Hydrazones; Infant; Milrinone; Pediatrics; Practice Patterns, Physicians'; Pyridazines; Simendan; Surveys and Questionnaires | 2011 |
Beneficial effects of levosimendan in infants with sepsis-associated cardiac dysfunction: report of 2 cases.
Topics: Cardiac Output; Cardiac Output, Low; Cardiotonic Agents; Humans; Hydrazones; Infant; Infusions, Intravenous; Male; Myocardial Contraction; Pyridazines; Shock, Septic; Simendan | 2012 |
Preliminary clinical experience with the repetitive administration of levosimendan in patients with end-stage heart failure.
Topics: Adolescent; Adult; Aged; Biomarkers; Blood Pressure; Calcium Channels, L-Type; Cardiac Output, Low; Cardiotonic Agents; Diastole; Dobutamine; Dopamine; Drug Therapy, Combination; Echocardiography; Electrocardiography; Female; Follow-Up Studies; Greece; Heart Failure; Heart Ventricles; Hematocrit; Hemoglobins; Humans; Hydrazones; Infusions, Intravenous; Male; Middle Aged; Myocardial Contraction; Potassium; Pyridazines; Severity of Illness Index; Simendan; Stimulation, Chemical; Survival Analysis; Systole; Treatment Outcome; Ventricular Dysfunction, Left | 2003 |
[Levosimendan-long-term inodilation in an infant with myocardial infarction].
Topics: Cardiac Output, Low; Cardiotonic Agents; Coronary Stenosis; Coronary Vessel Anomalies; Echocardiography, Doppler; Electrocardiography, Ambulatory; Humans; Hydrazones; Hypertension, Pulmonary; Infant; Infant, Newborn; Long-Term Care; Male; Myocardial Infarction; Postoperative Complications; Pulmonary Artery; Pulmonary Wedge Pressure; Pyridazines; Simendan; Stroke Volume; Treatment Outcome; Vascular Resistance; Vasodilator Agents | 2004 |
End-stage heart failure with pulmonary hypertension: levosimendan to evaluate for heart transplantation alone versus combined heart-lung transplantation.
Topics: Adolescent; Cardiac Output, Low; Cardiotonic Agents; Heart Transplantation; Heart-Lung Transplantation; Humans; Hydrazones; Hypertension, Pulmonary; Male; Pyridazines; Simendan | 2004 |
Levosimendan may improve survival in patients requiring mechanical assist devices for post-cardiotomy heart failure.
Topics: Aged; Cardiac Output, Low; Cardiac Surgical Procedures; Female; Heart-Assist Devices; Humans; Hydrazones; Intensive Care Units; Male; Middle Aged; Postoperative Complications; Pyridazines; Retrospective Studies; Simendan; Survival Rate; Vasodilator Agents | 2006 |
Effects of levosimendan on systemic and regional hemodynamics in septic myocardial depression.
Topics: Belgium; Cardiac Output, Low; Humans; Hydrazones; Pyridazines; Shock, Septic; Simendan; Vasodilator Agents | 2006 |
Early experience with Levosimendan in children with ventricular dysfunction.
Topics: Adolescent; Cardiac Output, Low; Cardiotonic Agents; Catecholamines; Child; Child, Preschool; Cohort Studies; Critical Illness; Humans; Hydrazones; Infant; Infant, Newborn; Intensive Care Units, Pediatric; Pyridazines; Retrospective Studies; Simendan; Stroke Volume; Ultrasonography; Ventricular Dysfunction | 2006 |
[Effect of levosimendan treatment of myocardial stunning and low-output syndrome after cardiac surgery].
Topics: Cardiac Output, Low; Cardiac Surgical Procedures; Cardiotonic Agents; Humans; Hydrazones; Myocardial Stunning; Pyridazines; Simendan | 2006 |
Testing new drugs for heart failure in children.
Topics: Adolescent; Cardiac Output, Low; Cardiotonic Agents; Catecholamines; Child; Child, Preschool; Humans; Hydrazones; Infant; Milrinone; Pyridazines; Simendan | 2006 |
Mechanisms of a reduced cardiac output and the effects of milrinone and levosimendan in a model of infant cardiopulmonary bypass.
Topics: Age Factors; Animals; Cardiac Output; Cardiac Output, Low; Cardiopulmonary Bypass; Cardiotonic Agents; Diastole; Disease Models, Animal; Drug Evaluation, Preclinical; Heart Rate; Humans; Hydrazones; Infant; Milrinone; Oxygen Consumption; Pulmonary Gas Exchange; Pyridazines; Risk Factors; Simendan; Swine; Time Factors; Vascular Resistance; Ventricular Function, Left | 2007 |
Use of levosimendan, a new inodilator, for postoperative myocardial stunning in a premature neonate.
Topics: Cardiac Output, Low; Cardiotonic Agents; Echocardiography; Follow-Up Studies; Gestational Age; Heart Failure; Humans; Hydrazones; Infant; Infant, Newborn; Infant, Premature, Diseases; Intensive Care Units, Pediatric; Male; Myocardial Stunning; Postoperative Complications; Pyridazines; Simendan; Time Factors; Transposition of Great Vessels; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left | 2007 |
Myocardial depression associated with pneumococcal septic shock reversed by levosimendan.
Topics: Aged; Cardiac Output, Low; Female; Humans; Hydrazones; Pneumococcal Infections; Pyridazines; Shock, Septic; Simendan; Vasodilator Agents | 2007 |
Levosimendan infusion improves haemodynamics in elderly heart failure patients undergoing urgent hip fracture repair.
Topics: Aged; Aged, 80 and over; Cardiac Output, Low; Cardiotonic Agents; Emergencies; Female; Heart Failure; Hemodynamics; Hip Fractures; Humans; Hydrazones; Infusions, Intravenous; Male; Natriuretic Peptides; Patient Selection; Preoperative Care; Pyridazines; Simendan; Survival Rate; Time Factors; Treatment Outcome; Troponin | 2008 |
[Levosimendan and low cardiac output syndrome. Does mortality really decrease? ].
Topics: Cardiac Output, Low; Cardiotonic Agents; Humans; Hydrazones; Pyridazines; Simendan | 2008 |
[Calcium sensitizers--a new group of drugs that increase myocardium contractility].
Topics: Animals; Calcium; Cardiac Output, Low; Cardiotonic Agents; Clinical Trials as Topic; Heart; Heart Failure; Humans; Hydrazones; Myocardial Contraction; Pyridazines; Simendan; Ventricular Function, Left | 2000 |